Prosecution Insights
Last updated: April 19, 2026
Application No. 18/294,271

METHOD AND SYSTEM FOR ULTRASOUND PARAMETER IDENTIFICATION

Non-Final OA §101§103§112
Filed
Feb 01, 2024
Examiner
CWERN, JONATHAN
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Koninklijke Philips N V
OA Round
1 (Non-Final)
50%
Grant Probability
Moderate
1-2
OA Rounds
4y 2m
To Grant
87%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allow Rate
402 granted / 797 resolved
-19.6% vs TC avg
Strong +36% interview lift
Without
With
+36.3%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
51 currently pending
Career history
848
Total Applications
across all art units

Statute-Specific Performance

§101
4.0%
-36.0% vs TC avg
§103
48.9%
+8.9% vs TC avg
§102
14.0%
-26.0% vs TC avg
§112
26.5%
-13.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 797 resolved cases

Office Action

§101 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 11 is rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. The broadest reasonable interpretation of a claim drawn to a computer readable medium (also called machine readable medium and other such variations) typically covers forms of non-transitory tangible media and transitory propagating signals per se in view of the ordinary and customary meaning of computer readable media, particularly when the specification is silent. See MPEP 2111.01. When the broadest reasonable interpretation of a claim covers a signal per se, the claim must be rejected under 35 U.S.C. § 101 as covering non-statutory subject matter. See In re Nuitjen, 500 F.3d 1346, 1356-57 (Fed. Cir. 2007) (transitory embodiments are not directed to statutory subject matter). A claim drawn to such a computer readable medium that covers both transitory and non-transitory embodiments may be amended to narrow the claim to cover only statutory embodiments to avoid a rejection under 35 U.S.C.§101 by adding the limitation “non-transitory” to the claim. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 10 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claim 10, the limitation “checking if the output B-mode gain value the global image entropy of the B-mode ultrasound image resulting from the output B-mode gain value is within the target entropy range” renders the claim indefinite. The language “output B-mode gain value the global image entropy” appears to be grammatically incorrect. Also, it is unclear what is meant by the language “resulting from” in this context. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-3, 6-8, and 10-15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Freiburger et al. (US 2019/0261952; hereinafter Freiburger) in view of Kim et al. (US 2012/0123265; hereinafter Kim). Freiburger shows a system and computer implemented method for identifying a gain parameter value for ultrasound hemodynamic analysis, comprising: obtaining a B-mode ultrasound image of a blood vessel ([0022]-[0025]); determining a global B-mode gain value ([0043], [0056]); identifying a region of interest of the B-mode ultrasound image resulting from the global B-mode gain value (location in field of view; [0044], [0057]-[0058]); and determining an output B-mode gain value based on a contrast-to-noise ratio of the region of interest (signal to noise ratio used to optimize gain; [0043], [0055]). Freiburger also shows wherein adjusting the initial B-mode gain value to determine the global B-mode gain value comprises one of: increasing the global B-mode gain value from the initial B-mode gain value; or decreasing the global B-mode gain value from the initial B-mode gain value (gain increased or decreased for optimization; [0055]-[0056]); wherein identifying the region of interest comprises: obtaining color/power Doppler data corresponding to the B-mode ultrasound image resulting from the global B-mode gain value ([0029]); identifying the blood vessel in the B-mode ultrasound image resulting from the global B-mode gain value based on the obtained color/power Doppler data ([0030]); and determining the region of interest based on a diameter of the blood vessel and a direction of the blood vessel ([0035]); wherein determining the output B-mode gain value comprises: calculating the contrast-to-noise ratio of the region of interest of the B-mode ultrasound image resulting from the global B-mode gain value ([0057]); and determining the output B-mode gain value by adjusting the global B-mode gain value to result in an increase in the contrast to noise ratio of the region of interest ([0057]); wherein determining the output B- mode gain value comprises: identifying a value of the output B-mode gain value which results in a maximized contrast to noise ratio in the region of interest ([0057]); wherein the ultrasound monitor comprises a wearable ultrasound sensor or an ultrasound patch (as the transducer is configured to be in contact with the patient’s tissue, it may be considered wearable or a patch; [0075]); wherein the ultrasound monitor comprises a one dimensional ultrasonic array ([0075]). Freiburger fails to show a global image entropy of the B-mode ultrasound image being within a target entropy range. Freiburger also fails to show: calculating the global image entropy of the B-mode ultrasound image; checking if the output B-mode gain value the global image entropy of the B-mode ultrasound image resulting from the output B-mode gain value is within the target entropy range. Kim discloses techniques for ultrasound image enhancement based on entropy information. Kim teaches a global image entropy of the B-mode ultrasound image being within a target entropy range (compare entropy information with threshold, [0034]). Kim also teaches calculating the global image entropy of the B-mode ultrasound image (calculate entropy information corresponding with the ultrasound data; [0027]-[0033]); checking if the output B-mode gain value the global image entropy of the B-mode ultrasound image resulting from the output B-mode gain value is within the target entropy range (compare entropy information with threshold, [0034]) It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the gain optimization techniques of Freiburger to utilize entropy information as taught Kim, as entropy information is a known ultrasound diagnostic parameter which correlates with sudden changes which may occur during the imaging procedure as described by Kim ([0005]) and as utilizing entropy information will improve the overall quality of the image by reducing noise as described by Kim ([0039]). It would be an obvious modification of the gain optimization techniques for Freiburger to utilize other known ultrasound imaging parameters such as entropy as taught by Kim, in order to provide a more accurate enhanced image of patient’s tissue. Claim(s) 4-5 is/are rejected under 35 U.S.C. 103 as being unpatentable over Freiburger et al. (US 2019/0261952; hereinafter Freiburger) in view of Kim et al. (US 2012/0123265; hereinafter Kim) as applied to claim 1 above, and further in view of Tretter (US 6463173). Freiburger fails to show wherein the obtained B-mode ultrasound image results from an initial B-mode gain value, and wherein determining the global B-mode gain value comprises: plotting a cumulative histogram of image entropy of the B-mode ultrasound image resulting from the initial B-mode gain value; determining the global B-mode gain value by adjusting the initial B-mode gain value, such that a log-average of the image entropy of the B-mode ultrasound image resulting from the global B- mode gain is within the target entropy range; wherein the target entropy range is a range of log-averages of the cumulative histogram, the range of log-averages selected such that a common carotid artery, CCA, of corresponding B-mode ultrasound images may be detected. Tretter discloses systems and methods for histogram-based image contrast enhancement. Tretter teaches plotting a cumulative histogram of image entropy of the B-mode ultrasound image resulting from the initial B-mode gain value; determining the global B-mode gain value by adjusting the initial B-mode gain value, such that a log-average of the image entropy of the B-mode ultrasound image resulting from the global B- mode gain is within the target entropy range (average log likelihood stored; column 9, lines 30-40); wherein the target entropy range is a range of log-averages of the cumulative histogram, the range of log-averages selected such that a common carotid artery, CCA, of corresponding B-mode ultrasound images may be detected (average log likelihood stored; column 9, lines 30-40). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the combined invention of Freiburger and Kim to utilize mathematical algorithms including histograms and log averages as taught by Tretter, as such mathematical algorithms are known within the art of imaging and provide for improved image contrast enhancement as described by Tretter (abstract). Furthermore, in regards to specific anatomy such as the common carotid artery, it is noted that Freiburger additionally teaches imaging of the carotid artery ([0040]), and it would be within the level of one of ordinary skill in the art to adapt the imaging technique for any particular part of the patient’s anatomy as desired by the operator and depending on the patient’s disease state. Claim(s) 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Freiburger et al. (US 2019/0261952; hereinafter Freiburger) in view of Kim et al. (US 2012/0123265; hereinafter Kim) as applied to claim 8 above, and further in view of Hasegawa (US 2022/0125403). Freiburger fails to show wherein calculating the contrast- to-noise ratio is based on a difference between an average intensity of pixels in the region of interest corresponding to a tissue wall of the blood vessel and an average intensity of pixels in the region of interest corresponding to a background region, and wherein calculating the contrast-to-noise ratio is further based on a variance of intensity of pixels in the background region of the region of interest. Hasegawa discloses ultrasound imaging systems and methods. Hasegawa teaches calculating the contrast- to-noise ratio is based on a difference between an average intensity of pixels in the region of interest corresponding to a tissue wall of the blood vessel and an average intensity of pixels in the region of interest corresponding to a background region, and wherein calculating the contrast-to-noise ratio is further based on a variance of intensity of pixels in the background region of the region of interest (estimate signal to noise based on average value and variance, [0027]). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to have modified the combined invention of Freiburger and Kim to calculate contrast/signal to noise ratio using known statistical measurements such as average and variance as taught by Hasegawa, as a variety of known techniques for calculating a signal to noise ratio are known in the art, and it would be an obvious design choice to one of ordinary skill in the art, without undue experimentation, to select an appropriate manner of calculation. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JONATHAN CWERN whose telephone number is (571)270-1560. The examiner can normally be reached Monday - Friday, 8:00 am - 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christopher Koharski can be reached at (571) 272-7230. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JONATHAN CWERN/Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Feb 01, 2024
Application Filed
Nov 06, 2025
Non-Final Rejection — §101, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12590949
A Radiomics-Based Imaging Tool to Monitor Tumor-Lymphocyte Infiltration and Outcome in Cancer Patients Treated by Anti-PD-1/PD-L1
2y 5m to grant Granted Mar 31, 2026
Patent 12588897
VISCOELASTICITY MEASUREMENT METHOD AND ULTRASONIC IMAGING SYSTEM
2y 5m to grant Granted Mar 31, 2026
Patent 12564313
SYSTEMS AND METHODS OF INTEGRATED REAL-TIME VISUALIZATION
2y 5m to grant Granted Mar 03, 2026
Patent 12564374
SPINAL CEREBRAL ARTERY RUPTURE DETECTOR
2y 5m to grant Granted Mar 03, 2026
Patent 12558576
SYSTEM FOR NERVE MODULATION AND INNOCUOUS THERMAL GRADIENT NERVE BLOCK
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
50%
Grant Probability
87%
With Interview (+36.3%)
4y 2m
Median Time to Grant
Low
PTA Risk
Based on 797 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month